EntryPoint Capital’s BioMarin Pharmaceuticals BMRN Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2025 Q2	$256K	Buy	+4,662	New	+$256K	0.13%	361
2024 Q4	–	Sell	-4,526	Closed	-$318K	–	736
2024 Q3	$318K	Buy	+4,526	New	+$318K	0.18%	226
2024 Q2	–	Sell	-1,217	Closed	-$106K	–	943
2024 Q1	$106K	Buy	+1,217	New	+$106K	0.1%	387